Vojtěch Novohradský

Statistics

Publications

Citations

2.2K

H-Index

Active since

2012

Affiliations

Czech Academy of Sciences, Institute of Biophysics(Current)

Palacký University Olomouc

Czech Academy of Sciences

Universidad de Murcia

Hebrew University of Jerusalem

Vojtěch Novohradský is an author at Czech Academy of Sciences, Institute of Biophysics specializing in cancer pharmacology, pharmacology, and medicine.

ORCID

Publications per year

2012–2024

Publications

Towards Novel Photodynamic Anticancer Agents Generating Superoxide Anion Radicals: A Cyclometalated Ir<sup>III</sup>Complex Conjugated to a Far‐Red Emitting Coumarin

Vojtěch Novohradský, Anna Rovira, Cormac Hally et al. · Angewandte Chemie International Edition · 2019 · 200 citations

Medicine, Medicinal Chemistry, Oncology +11

Pt(<scp>iv</scp>) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action

Raji Raveendran, Jeremy Phillip Braude, Ezequiel Wexselblatt et al. · Chemical Science · 2016 · 180 citations · Full text

Medicine, Oncology, Pharmacology +8

A dual-targeting, apoptosis-inducing organometallic half-sandwich iridium anticancer complex

Vojtěch Novohradský, Lenka Zerzánková, Jana Štěpánková et al. · Metallomics · 2014 · 99 citations · Full text

Life Sciences, Cancer Biology, Oncology +16

New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells

Vojtěch Novohradský, Lenka Zerzánková, Jana Štěpánková et al. · Biochemical Pharmacology · 2015 · 90 citations

Medicine, Oncology, Pharmacology +15

Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands

Vojtěch Novohradský, Lenka Zerzánková, Jana Štěpánková et al. · Journal of Inorganic Biochemistry · 2014 · 77 citations

Medicine, Medicinal Chemistry, Oncology +7

1–5 of 48